{"id":"fecal-microbiota","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain or cramping"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Flatulence"}]},"_chembl":null,"_dailymed":{"setId":"99e5a37a-930c-4641-bcdd-7013ec1c15fe","title":"VOWST (FECAL MICROBIOTA SPORES, LIVE-BRPK) CAPSULE [AIMMUNE THERAPEUTICS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT works by transferring stool from a healthy donor into the gastrointestinal tract of a patient with dysbiosis, reestablishing beneficial bacterial populations and their metabolic functions. This restores microbial diversity and competitive exclusion of pathogenic organisms, particularly Clostridioides difficile. The restored microbiota produces short-chain fatty acids and other metabolites that support intestinal barrier function and immune homeostasis.","oneSentence":"Fecal microbiota transplantation (FMT) restores a healthy gut bacterial community by introducing donor microorganisms to treat dysbiosis-related conditions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:53:50.826Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (recurrent or refractory)"},{"name":"Ulcerative colitis"},{"name":"Crohn's disease"}]},"trialDetails":[{"nctId":"NCT06623461","phase":"PHASE2","title":"LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-04-07","conditions":"Melanoma","enrollment":128},{"nctId":"NCT06478602","phase":"PHASE3","title":"Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","status":"COMPLETED","sponsor":"Cristian Ichim","startDate":"2024-08-05","conditions":"Liver Cirrhosis","enrollment":19},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT06591013","phase":"NA","title":"Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD","status":"COMPLETED","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2022-10-14","conditions":"Inflammatory Bowel Diseases","enrollment":80},{"nctId":"NCT04090346","phase":"PHASE4","title":"Fecal Microbiota Transplant","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2018-06-05","conditions":"Clostridium Difficile Infection","enrollment":24},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT05669846","phase":"PHASE2","title":"Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-08","conditions":"Non Small Cell Lung Cancer","enrollment":26},{"nctId":"NCT06290258","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-03-06","conditions":"Autism Spectrum Disorder, Gastrointestinal Diseases, Healthy","enrollment":60},{"nctId":"NCT04038619","phase":"PHASE1","title":"Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-01","conditions":"Colitis, Diarrhea, Malignant Genitourinary System Neoplasm","enrollment":40},{"nctId":"NCT04975217","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-14","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":10},{"nctId":"NCT03068663","phase":"NA","title":"Microbiota and the Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Jean Perrin","startDate":"2017-05-23","conditions":"Non Small Cell Lung Cancer","enrollment":40},{"nctId":"NCT05998213","phase":"PHASE2","title":"Transfer of Feces in Ulcerative Colitis 2","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2020-06-12","conditions":"Ulcerative Colitis, Ulcerative Colitis Flare, Ulcerative Colitis Acute","enrollment":85},{"nctId":"NCT07486492","phase":"EARLY_PHASE1","title":"Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-03-31","conditions":"Colorectal Cancer Metastatic, Fecal Microbiota Transplantation","enrollment":10},{"nctId":"NCT05333471","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-08-08","conditions":"Chronic Granulomatous Disease-associated Colitis","enrollment":20},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT04759001","phase":"PHASE1, PHASE2","title":"FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-02-18","conditions":"Enterobacteriaceae Infections, Multi-antibiotic Resistance","enrollment":52},{"nctId":"NCT05739864","phase":"PHASE1, PHASE2","title":"Superdonor FMT in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Active Ulcerative Colitis","enrollment":42},{"nctId":"NCT06071312","phase":"PHASE1, PHASE2","title":"FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-09-23","conditions":"Clostridium Difficile, Ulcerative Colitis","enrollment":64},{"nctId":"NCT05739825","phase":"","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Clostridioides Difficile Infection Recurrence","enrollment":20},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT06181201","phase":"","title":"Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer","status":"TERMINATED","sponsor":"Centre Oscar Lambret","startDate":"2024-02-19","conditions":"Cancer of Rectum","enrollment":2},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07478029","phase":"","title":"Clinical Study of PEG Bowel Preparation in Appendectomy Patients","status":"RECRUITING","sponsor":"Huaping Xie","startDate":"2024-02-23","conditions":"Appendicitis, Appendicitis Acute","enrollment":10},{"nctId":"NCT07471373","phase":"NA","title":"Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-02-27","conditions":"Endometriosis, Infertility, Female Fertility","enrollment":160},{"nctId":"NCT06214403","phase":"PHASE2","title":"Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2026-07","conditions":"Gram-negative Bacteremia, Microbial Colonization, Antibiotic Resistant Infection","enrollment":""},{"nctId":"NCT07300553","phase":"PHASE2","title":"Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-02","conditions":"IBD, Crohn Disease, Ulcerative Colitis (UC)","enrollment":45},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT07463248","phase":"PHASE2","title":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Wang Xin","startDate":"2026-03-05","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":64},{"nctId":"NCT05067595","phase":"PHASE1","title":"Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-01-24","conditions":"Intestinal Graft Versus Host Disease","enrollment":72},{"nctId":"NCT07461610","phase":"","title":"Stool Analysis After Sleeve Gastrectomy vs Gastric Bypass","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03","conditions":"Morbid Obesity","enrollment":50},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT07205913","phase":"","title":"Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND","status":"NOT_YET_RECRUITING","sponsor":"Institut Pasteur","startDate":"2026-02-15","conditions":"Diabetes Mellitus, Type 2, Obesity","enrollment":270},{"nctId":"NCT03786900","phase":"","title":"Fecal Microbiota Transplantation (FMT): PRIM-DJ2727","status":"AVAILABLE","sponsor":"Herbert DuPont, MD","startDate":"","conditions":"Recurrent Clostridium Difficile Infection, Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection","enrollment":""},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07450872","phase":"","title":"Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors","status":"RECRUITING","sponsor":"The Children's Hospital of Zhejiang University School of Medicine","startDate":"2026-01-01","conditions":"Cancer, Glioma, Leukemia (Both ALL and AML)","enrollment":600},{"nctId":"NCT07452965","phase":"NA","title":"Pre-analytical Processing of Human Samples for Microbiota Analysis Quality","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Healthy","enrollment":10},{"nctId":"NCT07450807","phase":"NA","title":"Prospective Randomized Controlled Pilot Study of Gut Microbiome Modulation by Nigella Sativa Seed Oil and Thymoquinone Metabolism in Healthy Volunteers","status":"COMPLETED","sponsor":"Aysun Tekbaş","startDate":"2024-04-02","conditions":"Changes in Human Gut Microbiome in Healthy Adults","enrollment":8},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT06333795","phase":"NA","title":"Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2024-04-01","conditions":"Diarrhea, Systemic Sclerosis","enrollment":20},{"nctId":"NCT04924712","phase":"","title":"INS, B Cells and Microbiota","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2022-01-18","conditions":"Microbiota, B-lymphocytes, Glomerulosclerosis","enrollment":30},{"nctId":"NCT05917379","phase":"PHASE1, PHASE2","title":"The Efficacy and Safty of FMT in Patients With CID","status":"COMPLETED","sponsor":"Peking University Sixth Hospital","startDate":"2023-10-08","conditions":"Insomnia Chronic, Fecal Microbiota Transplantation, Sleep Disorder","enrollment":80},{"nctId":"NCT07439640","phase":"","title":"PEG Laxatives for Intestinal Preparation and Gut Microbiota in Cholecystectomy","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-01-16","conditions":"Cholecystectomy","enrollment":20},{"nctId":"NCT05740319","phase":"NA","title":"Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-06-10","conditions":"Irritable Bowel Syndrome","enrollment":102},{"nctId":"NCT07432984","phase":"PHASE2","title":"Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Se-Hoon Lee","startDate":"2026-04-30","conditions":"Non Small Cell Lung Cancer","enrollment":15},{"nctId":"NCT03934021","phase":"","title":"Gut Microbiota in Acute Stroke Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-07-01","conditions":"Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":120},{"nctId":"NCT07424989","phase":"","title":"Antibiotic Therapies for Urinary Tract Infections and Their Impact on the Gut Microbiota","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2021-07-04","conditions":"Urinary Tract Infection(UTI)","enrollment":61},{"nctId":"NCT06461208","phase":"PHASE3","title":"A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis","status":"RECRUITING","sponsor":"King's College London","startDate":"2023-06-21","conditions":"Liver Cirrhosis","enrollment":300},{"nctId":"NCT03562741","phase":"NA","title":"Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile","status":"RECRUITING","sponsor":"Krunal Patel","startDate":"2014-01-16","conditions":"Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection","enrollment":500},{"nctId":"NCT05965440","phase":"NA","title":"Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2023-11-20","conditions":"Chronic Kidney Diseases","enrollment":50},{"nctId":"NCT07421947","phase":"NA","title":"Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-04","conditions":"Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT07148271","phase":"NA","title":"Effect of a Dietary Supplement on Gut Microbiota and Ocular Surface Outcomes in Dry Eye Disease","status":"COMPLETED","sponsor":"Varol TUNALI","startDate":"2025-10-01","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Dry Eye Disease (DED)","enrollment":20},{"nctId":"NCT07418658","phase":"","title":"Untreated Parkinson's Disease Work-up Assessing Resident Microbiota and Duodenal Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-02","conditions":"Parkinson's Disease (PD)","enrollment":100},{"nctId":"NCT07417085","phase":"NA","title":"MICRO-BRAIN 2024: Study on Pediatric Brain Tumors","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-02-06","conditions":"Brain Tumor, Microbiota","enrollment":100},{"nctId":"NCT07416760","phase":"","title":"Analysis of the Composition of the Intestinal Microbiota in Patients Post-intestinal Anastomosis","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2026-02-14","conditions":"Abdominal Surgery","enrollment":30},{"nctId":"NCT06058520","phase":"EARLY_PHASE1","title":"Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2023-10-01","conditions":"Hidradenitis Suppurativa","enrollment":16},{"nctId":"NCT07407218","phase":"NA","title":"Fecal Microbiota And Metabolites In Head And Neck Cancer Patients Receiving (Chemo)Radiotherapy","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2021-09-01","conditions":"Head and Neck Cancer (H&N)","enrollment":58},{"nctId":"NCT04598295","phase":"PHASE2","title":"SH-DS01 on Fecal Metagenomic Stability","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-10-20","conditions":"Irritable Bowel Syndrome","enrollment":48},{"nctId":"NCT03524352","phase":"PHASE3","title":"the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2020-03-12","conditions":"Pouchitis","enrollment":42},{"nctId":"NCT07411131","phase":"NA","title":"A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-03","conditions":"Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)","enrollment":50},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT06100549","phase":"","title":"Feasibility of Using Surplus qFIT Samples to Investigate the Gut Microbiota.","status":"COMPLETED","sponsor":"University of Aberdeen","startDate":"2023-11-28","conditions":"Gut Microbiota","enrollment":116},{"nctId":"NCT07398820","phase":"","title":"IMPACT OF SEDENTARY BEHAVIOR IN THE HOMEOSTASIS OF THE DIGESTIVE ECOSYSTEM","status":"COMPLETED","sponsor":"Clínica Universidad de los Andes","startDate":"2023-05-01","conditions":"Healthy, Colorectal Adenoma","enrollment":80},{"nctId":"NCT06307964","phase":"","title":"Intra-Hepatic Microbiota in Alcoholic Hepatitis","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-07-23","conditions":"Cirrhosis, Alcoholic Liver Disease, Alcoholic Hepatitis","enrollment":50},{"nctId":"NCT07401680","phase":"PHASE1","title":"Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-03-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection","enrollment":85},{"nctId":"NCT05664113","phase":"PHASE1","title":"Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-07-07","conditions":"Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT06618677","phase":"NA","title":"Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome","status":"COMPLETED","sponsor":"University of Bari","startDate":"2023-01-01","conditions":"IBS, Functional Gastrointestinal Disorders","enrollment":70},{"nctId":"NCT05794620","phase":"","title":"Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings","status":"COMPLETED","sponsor":"East Suffolk and North Essex NHS Foundation Trust","startDate":"2022-12-20","conditions":"Autism Spectrum Disorder, Autism","enrollment":20},{"nctId":"NCT06499896","phase":"PHASE2","title":"Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-23","conditions":"Immune-mediated Colitis (IMC), Immune-related Dermatitis","enrollment":30},{"nctId":"NCT03385707","phase":"","title":"Hypoglycemia and the Gut Microbiome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Joslin Diabetes Center","startDate":"2019-02-07","conditions":"Hypoglycemia","enrollment":28},{"nctId":"NCT07385807","phase":"","title":"Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2026-02-01","conditions":"IBD (Inflammatory Bowel Disease), IBD, IBD - Inflammatory Bowel Disease","enrollment":80},{"nctId":"NCT07381140","phase":"","title":"Bariatric Surgery and Gut Microbiota Changes Over Time","status":"NOT_YET_RECRUITING","sponsor":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","startDate":"2026-04","conditions":"Obese Patients, Obese Patients With Bariatric Surgery, Gut Microbiota","enrollment":100},{"nctId":"NCT06603883","phase":"PHASE2, PHASE3","title":"Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-10-19","conditions":"Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","enrollment":60},{"nctId":"NCT06221800","phase":"","title":"Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-01-31","conditions":"Non Small Cell Lung Cancer","enrollment":82},{"nctId":"NCT07381374","phase":"NA","title":"Fecal Microbiota Transplantation in Children With ASD","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Children's Hospital","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":75},{"nctId":"NCT07386795","phase":"NA","title":"The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-02-01","conditions":"Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation","enrollment":19},{"nctId":"NCT06911177","phase":"NA","title":"Yeast Mannans and Stool Frequency","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-07-17","conditions":"Defecation Frequency","enrollment":70},{"nctId":"NCT07387952","phase":"NA","title":"The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation：a Pilot Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-30","conditions":"Constipation - Functional, Fecal Microbiota Transplantation (FMT), Chronic Constipation","enrollment":5},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT03983473","phase":"NA","title":"Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2021-11-16","conditions":"Crohn Disease, Spondyloarthritis","enrollment":240},{"nctId":"NCT05327790","phase":"PHASE2","title":"LFMT vs Placebo in New Biologic Start for Ulcerative Colitis","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-06-03","conditions":"Ulcerative Colitis","enrollment":40},{"nctId":"NCT07017946","phase":"PHASE1, PHASE2","title":"Intestinal Microbiome Transplant in ALS","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-27","conditions":"Amyotrophic Lateral Sclerosis ALS","enrollment":20},{"nctId":"NCT07374094","phase":"","title":"Clostridioides Difficile: Understanding Responses and Treatment Effects","status":"RECRUITING","sponsor":"Umeå University","startDate":"2026-01-26","conditions":"Clostridioides Difficile Infection","enrollment":200},{"nctId":"NCT07371013","phase":"NA","title":"Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2026-01","conditions":"Autism Spectrum Disorder, Gastrointestinal Symptoms","enrollment":20},{"nctId":"NCT07371325","phase":"NA","title":"Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. A Double-blind Placebo-controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Manuel Jesús Cuesta Zurita","startDate":"2024-09-08","conditions":"SCHIZOPHRENIA 1 (Disorder), Metabolic Abnormalities, Postbiotic Supplement","enrollment":36},{"nctId":"NCT07363304","phase":"","title":"Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-12-02","conditions":"Cystic Fibrosis (CF)","enrollment":150},{"nctId":"NCT07364617","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-02-01","conditions":"Graft vs Host Disease","enrollment":35},{"nctId":"NCT07143981","phase":"","title":"The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-15","conditions":"Anorexia Nervosa","enrollment":20},{"nctId":"NCT07243756","phase":"NA","title":"Gut Microbiome Pill","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2026-01-21","conditions":"Healthy","enrollment":10},{"nctId":"NCT06377956","phase":"","title":"The Associations Between Gut Length, Gut Microbiota and Food Assimilation","status":"COMPLETED","sponsor":"Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences","startDate":"2024-05-15","conditions":"Healthy Nutrition, Food Preferences, Metabolic Syndrome, Protection Against","enrollment":42},{"nctId":"NCT03325855","phase":"","title":"Fecal Microbiota Transplant National Registry","status":"RECRUITING","sponsor":"American Gastroenterological Association","startDate":"2017-09-20","conditions":"Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome","enrollment":4000},{"nctId":"NCT06153056","phase":"","title":"Identification of Factors Predictive of the Efficacy of Endoscopic Endoscopic Sleeve Gastroplasty","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09-09","conditions":"Obesity","enrollment":205},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07348471","phase":"NA","title":"Fecal Microbiota Transplantation for the Treatment of ICU Delirium","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-01","conditions":"Delirium","enrollment":60},{"nctId":"NCT07342205","phase":"PHASE2, PHASE3","title":"A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation","status":"RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-12-10","conditions":"Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome","enrollment":60},{"nctId":"NCT07345377","phase":"NA","title":"Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing","status":"ENROLLING_BY_INVITATION","sponsor":"The Affiliated Hospital of Hangzhou Normal University","startDate":"2022-01-01","conditions":"Irritable Bowel Syndrome (IBS), Pain, Depressive Disorder, Major, Moderate","enrollment":160},{"nctId":"NCT07345403","phase":"","title":"GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-01-01","conditions":"Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury","enrollment":3000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11801,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["stool transplant","fecal microbial transplantation","FMT","Washed fecal microbiota","FMT Therapy"],"phase":"marketed","status":"active","brandName":"Fecal Microbiota","genericName":"Fecal Microbiota","companyName":"University of California, San Francisco","companyId":"university-of-california-san-francisco","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fecal microbiota transplantation (FMT) restores a healthy gut bacterial community by introducing donor microorganisms to treat dysbiosis-related conditions. Used for Clostridioides difficile infection (recurrent or refractory), Ulcerative colitis, Crohn's disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}